About Blueprint Medicines
Blueprint Medicines is a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer immunotherapy, we are developing transformational medicines rooted in our leading expertise in protein kinases, which are proven drivers of disease. Our uniquely targeted, scalable approach empowers the rapid design and development of new treatments and increases the likelihood of clinical success. We have one FDA-approved precision therapy and are currently advancing multiple investigational medicines in clinical development, along with a number of research programs.
|Shannan Coleman||850-519-7367||[email protected]||Gainesville|
|Nydia Llanes||929-332-3180||[email protected]||Miami|
|Mercy Padron||407-489-2384||[email protected]||Orlando|
|Heather Scott||813-928-5111||[email protected]||Tampa|